ThermoGenesis (THMO) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock THMO vs. HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, VLTO, FTV, and TERShould you be buying ThermoGenesis stock or one of its competitors? The main competitors of ThermoGenesis include HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), Veralto (VLTO), Fortive (FTV), and Teradyne (TER). These companies are all part of the "measuring and control equipment" industry. ThermoGenesis vs. Its Competitors HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Veralto Fortive Teradyne HTG Molecular Diagnostics (NASDAQ:HTGMQ) and ThermoGenesis (NASDAQ:THMO) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment, community ranking and dividends. Do institutionals and insiders have more ownership in HTGMQ or THMO? 5.8% of ThermoGenesis shares are held by institutional investors. 2.6% of HTG Molecular Diagnostics shares are held by insiders. Comparatively, 78.0% of ThermoGenesis shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media favor HTGMQ or THMO? In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score. Company Overall Sentiment HTG Molecular Diagnostics Neutral ThermoGenesis Neutral Which has preferable earnings and valuation, HTGMQ or THMO? ThermoGenesis has higher revenue and earnings than HTG Molecular Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/AThermoGenesis$9.61M0.00-$17.98M-$5.14N/A Which has more volatility & risk, HTGMQ or THMO? HTG Molecular Diagnostics has a beta of 2.72, indicating that its share price is 172% more volatile than the S&P 500. Comparatively, ThermoGenesis has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Is HTGMQ or THMO more profitable? Company Net Margins Return on Equity Return on Assets HTG Molecular DiagnosticsN/A N/A N/A ThermoGenesis N/A N/A N/A Does the MarketBeat Community favor HTGMQ or THMO? ThermoGenesis received 26 more outperform votes than HTG Molecular Diagnostics when rated by MarketBeat users. CompanyUnderperformOutperformHTG Molecular DiagnosticsN/AN/AThermoGenesisOutperform Votes2660.47% Underperform Votes1739.53% SummaryThermoGenesis beats HTG Molecular Diagnostics on 5 of the 6 factors compared between the two stocks. Get ThermoGenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for THMO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding THMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart THMO vs. The Competition Export to ExcelMetricThermoGenesisLaboratory apparatus & furniture IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$105.81M$5.57B$8.50BDividend YieldN/AN/A5.28%4.16%P/E Ratio0.005.8726.6319.64Price / SalesN/A0.48407.99152.17Price / CashN/A45.3038.2534.64Price / BookN/A2.736.964.60Net Income-$17.98M$18.75M$3.23B$248.06M ThermoGenesis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)THMOThermoGenesisN/AN/AN/AN/A$1K$9.61M0.0040HTGMQHTG Molecular DiagnosticsN/A$0.00flatN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.07+7.7%N/A-5.4%$0.00N/A0.003Gap UpPRENWPrenetics GlobalN/A$0.01-6.6%N/A+22.4%$0.00$30.62M0.001Short Interest ↓QSIAWQuantum-SiN/A$0.71+6.0%N/A+275.6%$0.00$3.44M0.00150SMAPWSportsMap Tech AcquisitionN/A$0.04+0.2%N/A+49.8%$0.00N/A0.00N/ATTTrane Technologies4.3879 of 5 stars$421.70-1.4%$427.47+1.4%+26.2%$94.10B$20.31B37.5139,000Positive NewsKEYSKeysight Technologies4.1759 of 5 stars$163.34+0.5%$183.00+12.0%+14.6%$28.09B$5.11B46.6315,000Analyst RevisionVLTOVeralto4.1661 of 5 stars$99.94+0.2%$110.09+10.2%-3.8%$24.76B$5.28B29.9016,000Positive NewsFTVFortive4.7458 of 5 stars$72.43-1.1%$82.62+14.1%-5.0%$24.64B$6.18B30.7218,000Positive NewsTERTeradyne4.8141 of 5 stars$88.52+2.0%$114.67+29.5%-43.7%$14.17B$2.91B26.526,500Positive NewsAnalyst RevisionGap Down Related Companies and Tools Related Companies HTGMQ Competitors OLITW Competitors PRENW Competitors QSIAW Competitors SMAPW Competitors TT Competitors KEYS Competitors VLTO Competitors FTV Competitors TER Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:THMO) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ThermoGenesis Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ThermoGenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
